| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8778623 | European Urology | 2018 | 8 Pages |
Abstract
Papillary renal cell carcinoma (PRCC) is a rare subtype of kidney cancer, and understanding of the biology of advanced PRCC is limited. This report highlights some of the unique biologic features of PRCC that may inform on future use of targeted therapies for the treatment of metastatic disease.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Sumanta K. Pal, Siraj M. Ali, Evgeny Yakirevich, Daniel M. Geynisman, Jose A. Karam, Julia A. Elvin, Garrett M. Frampton, Xuan Huang, Douglas I. Lin, Mark Rosenzweig, Doron Lipson, Philip J. Stephens, Jeffrey S. Ross, Vincent A. Miller, Neeraj Agarwal,